Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis

dc.contributor.author	ÖZARAS, Reşat
dc.contributor.author	YEMİŞEN, Mücahit
dc.contributor.author	METE, Bilgül
dc.contributor.author	Balkan, Ilker Inanc
dc.contributor.author	ALkan, Mustafa
dc.contributor.author	Tabak, Fehmi
dc.date.accessioned	2021-03-05T15:10:53Z
dc.date.available	2021-03-05T15:10:53Z
dc.identifier.citation	ÖZARAS R., METE B., YEMİŞEN M., Balkan I. I. , ALkan M., Tabak F., "Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis", The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Tokyo, Japonya, 20 - 24 Şubat 2016, cilt.1, ss.1
dc.identifier.other	vv_1032021
dc.identifier.other	av_baaba819-03c1-4dba-b944-ffed12addc6a
dc.identifier.uri	http://hdl.handle.net/20.500.12627/124147
dc.language.iso	eng
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.title	Daclatasvir and Asunaprevir for Treatment of Posttransplant Hepatitis C Virus Cirrhosis
dc.type	Bildiri
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	1
dc.contributor.firstauthorID	657139

Files in this item

Files	Size	Format	View
There are no files associated with this item.